Literature DB >> 17345077

Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function.

Markus Jaggi1, Yasushi Nakagawa, Ljerka Zipperle, Bernhard Hess.   

Abstract

Tamm-Horsfall protein (THP) powerfully inhibits calcium oxalate crystal aggregation, but structurally abnormal THPs from recurrent calcium stone formers may promote crystal aggregation. Therefore, increased urinary excretion of abnormal THP might be of relevance in nephrolithiasis. We studied 44 recurrent idiopathic calcium stone formers with a positive family history of stone disease (RCSF(fam)) and 34 age- and sex-matched healthy controls (C). Twenty-four-hour urinary THP excretion was measured by enzyme linked immunosorbent assay. Structural properties of individually purified THPs were obtained from analysis of elution patterns from a Sepharose 4B column. Sialic acid (SA) contents of native whole 24-h urines, crude salt precipitates of native urines and individually purified THPs were measured. THP function was studied by measuring inhibition of CaOx crystal aggregation in vitro (pH 5.7, 200 mM sodium chloride). Twenty-four-hour urine excretion of THP was higher in RCSF(fam) (44.0 +/- 4.0 mg/day) than in C (30.9 +/- 2.2 mg/day, P = 0.015). Upon salt precipitation and lyophilization, elution from a Sepharose 4B column revealed one major peak (peak A, cross-reacting with polyclonal anti-THP antibody) and a second minor peak (peak B, not cross-reacting). THPs from RCSF(fam) eluted later than those from C (P = 0.021), and maximum width of THP peaks was higher in RCSF(fam )than in C (P = 0.024). SA content was higher in specimens from RCSF(fam) than from C, in native 24-h urines (207.5 +/- 20.4 mg vs. 135.2 +/- 16.1 mg, P = 0.013) as well as in crude salt precipitates of 24-h urines (10.4 +/- 0.5 mg vs. 7.4 +/- 0.9 mg, P = 0.002) and in purified THPs (75.3 +/- 9.3 microg/mg vs. 48.8 +/- 9.8 microg/mg THP, P = 0.043). Finally, inhibition of calcium oxalate monohydrate crystal aggregation by 40 mg/L of THP was lower in RCSF(fam) (6.1 +/- 5.5%, range -62.0 to +84.2%) than in C (24.9 +/- 6.0%, range -39.8 to +82.7%), P = 0.022, and only 25 out of 44 (57%) THPs from RCSF(fam )were inhibitory (positive inhibition value) vs. 25 out of 34 (74%) THPs from C, P < 0.05. In conclusion, severely recurrent calcium stone formers with a positive family history excrete more THP than healthy controls, and their THP molecules elute later from an analytical column and contain more SA. Such increasingly aggregated THP molecules predispose to exaggerated calcium oxalate crystal aggregation, an important prerequisite for urinary stone formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17345077     DOI: 10.1007/s00240-007-0083-7

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  28 in total

Review 1.  Tamm-Horsfall protein--uromodulin (1950-1990).

Authors:  S Kumar; A Muchmore
Journal:  Kidney Int       Date:  1990-06       Impact factor: 10.612

2.  Calcium oxalate nephrolithiasis, a free or fixed particle disease.

Authors:  D J Kok; S R Khan
Journal:  Kidney Int       Date:  1994-09       Impact factor: 10.612

3.  Molecular abnormality of Tamm-Horsfall glycoprotein in calcium oxalate nephrolithiasis.

Authors:  B Hess; Y Nakagawa; J H Parks; F L Coe
Journal:  Am J Physiol       Date:  1991-04

4.  Beneficial effect of vitamin E supplementation on the biochemical and kinetic properties of Tamm-Horsfall glycoprotein in hypertensive and hyperoxaluric patients.

Authors:  Kamalanathan Sumitra; Viswanathan Pragasam; Ramasamy Sakthivel; Periandavan Kalaiselvi; Palaninathan Varalakshmi
Journal:  Nephrol Dial Transplant       Date:  2005-04-26       Impact factor: 5.992

5.  Excretion of tamm-horsfall protein in patients with uric acid stones.

Authors:  K Bichler; B Mittermüller; W L Strohmaier; G Feil; E Eipper
Journal:  Urol Int       Date:  1999       Impact factor: 2.089

Review 6.  Role of renal epithelial cells in the initiation of calcium oxalate stones.

Authors:  Saeed R Khan
Journal:  Nephron Exp Nephrol       Date:  2004

7.  Uromucoid excretion in normal subjects, calcium stone formers and in patients with chronic renal failure.

Authors:  C T Samuell
Journal:  Urol Res       Date:  1979-03-23

8.  Human Tamm-Horsfall glycoprotein: urinary and plasma levels in normal subjects and patients with renal disease determined by a fully validated radioimmunoassay.

Authors:  C Thornley; A Dawnay; W R Cattell
Journal:  Clin Sci (Lond)       Date:  1985-05       Impact factor: 6.124

9.  Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins.

Authors:  B Hess; Y Nakagawa; F L Coe
Journal:  Am J Physiol       Date:  1989-07

10.  Effects of Tamm-Horsfall protein on polymorphonuclear leukocyte function.

Authors:  Thomas Wimmer; Gerald Cohen; Marcus D Saemann; Walter H Hörl
Journal:  Nephrol Dial Transplant       Date:  2004-07-20       Impact factor: 5.992

View more
  16 in total

1.  An evaluation of Tamm-Horsfall protein glycans in kidney stone formers using novel techniques.

Authors:  Sulabha Argade; Tony Chen; Timothy Shaw; Zoltan Berecz; William Shi; Biswa Choudhury; C Lowell Parsons; Roger L Sur
Journal:  Urolithiasis       Date:  2015-05-03       Impact factor: 3.436

2.  Incorporation of osteopontin peptide into kidney stone-related calcium oxalate monohydrate crystals: a quantitative study.

Authors:  Jared S Gleberzon; Yinyin Liao; Silvia Mittler; Harvey A Goldberg; Bernd Grohe
Journal:  Urolithiasis       Date:  2018-12-19       Impact factor: 3.436

3.  Aggregation of freshly precipitated calcium oxalate crystals in urine of calcium stone patients and controls.

Authors:  J M Baumann; B Affolter; R Casella
Journal:  Urol Res       Date:  2011-05-13

4.  Calcium oxalate monohydrate aggregation induced by aggregation of desialylated Tamm-Horsfall protein.

Authors:  Pragasam Viswanathan; Jeffrey D Rimer; Ann M Kolbach; Michael D Ward; Jack G Kleinman; Jeffrey A Wesson
Journal:  Urol Res       Date:  2011-01-13

Review 5.  What is nephrocalcinosis?

Authors:  Linda Shavit; Philippe Jaeger; Robert J Unwin
Journal:  Kidney Int       Date:  2015-03-25       Impact factor: 10.612

6.  Stone former urine proteome demonstrates a cationic shift in protein distribution compared to normal.

Authors:  Ann M Kolbach-Mandel; Neil S Mandel; Brian R Hoffmann; Jack G Kleinman; Jeffrey A Wesson
Journal:  Urolithiasis       Date:  2017-03-17       Impact factor: 3.436

7.  Calcium urolithiasis course in young stone formers is influenced by the strength of family history: results from a retrospective study.

Authors:  Angela Guerra; Andrea Ticinesi; Franca Allegri; Antonio Nouvenne; Silvana Pinelli; Fulvio Lauretani; Marcello Maggio; Gianfranco Cervellin; Loris Borghi; Tiziana Meschi
Journal:  Urolithiasis       Date:  2016-12-09       Impact factor: 3.436

Review 8.  Nephrocalcinosis in animal models with and without stones.

Authors:  Saeed R Khan
Journal:  Urol Res       Date:  2010-07-24

Review 9.  Interstitial calcinosis in renal papillae of genetically engineered mouse models: relation to Randall's plaques.

Authors:  Xue-Ru Wu
Journal:  Urolithiasis       Date:  2014-08-06       Impact factor: 3.436

10.  Regulation of macromolecular modulators of urinary stone formation by reactive oxygen species: transcriptional study in an animal model of hyperoxaluria.

Authors:  Saeed R Khan; Sunil Joshi; Wei Wang; Ammon B Peck
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.